NOVEL PHARMACEUTICAL FORMULATION COMPRISING A STING MODULATOR
Disclosed are novel pharmaceutical formulations comprising (E)-1-(4-(5-Carbamoyl-2-(1-ethyl-3-methyl-1H-pyrazole-5-carboxamido)-7-(3-morpholinopropoxy)-1H-benzo[d]imidazol-1-yl)but-2-en-1-yl)-2-(1-ethyl-3-methyl-1H-pyrazole-5-carboxamido)-7-methoxy-1H-benzo[d]imidazole-5-carboxamide, processes for p...
Saved in:
Main Authors | , |
---|---|
Format | Patent |
Language | English French German |
Published |
06.09.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Disclosed are novel pharmaceutical formulations comprising (E)-1-(4-(5-Carbamoyl-2-(1-ethyl-3-methyl-1H-pyrazole-5-carboxamido)-7-(3-morpholinopropoxy)-1H-benzo[d]imidazol-1-yl)but-2-en-1-yl)-2-(1-ethyl-3-methyl-1H-pyrazole-5-carboxamido)-7-methoxy-1H-benzo[d]imidazole-5-carboxamide, processes for preparing the same, and methods of using the same. |
---|---|
Bibliography: | Application Number: EP20190821281 |